triazoles has been researched along with Critical Illness in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (29.55) | 29.6817 |
| 2010's | 19 (43.18) | 24.3611 |
| 2020's | 12 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Eller, P; Gorkiewicz, G; Hatzl, S; Hoenigl, M; Krause, R; Metnitz, P; Pilz, S; Posch, F; Prattes, J; Prüller, F; Reisinger, AC; Rief, M; Rosenkranz, AR; Schilcher, G; Schoerghuber, M; Stradner, M; Toller, W; Valentin, T | 1 |
| Boelens, J; Brüggemann, RJ; Dreesen, E; Jacobs, C; Lormans, P; Nulens, E; Rijnders, B; Spriet, I; Van Daele, R; Vanderbeke, L; Verweij, PE; Wauters, J | 1 |
| Eller, P; Gringschl, Y; Hatzl, S; Hoenigl, M; Krause, R; Kriegl, L; Meinitzer, A; Muhr, T; Prattes, J; Reisinger, AC; Schilcher, G; Zurl, C | 1 |
| Brüggemann, R; Debaveye, Y; Gijsen, M; Mertens, B; Spriet, I; Van Daele, R; Vandenbriele, C; Wauters, J | 1 |
| Hatzl, S; Hoenigl, M; Krause, R; Kriegl, L; Schilcher, G | 1 |
| Brüggemann, RJM; Debaveye, Y; Jansen, AME; Mertens, B; Schouten, J; Spriet, I; Ter Heine, R; Verweij, PE; Wauters, J | 1 |
| Batres Baires, G; Heilmaier, M; Huber, W; Kinzig, M; Lahmer, T; Mayr, U; Rasch, S; Schmid, RM; Sörgel, F | 1 |
| Adams, AD; Brown, JN; Pepin, MJ | 1 |
| Brüggemann, RJ; Cotton, F; Debaveye, Y; Depuydt, P; Dreesen, E; Fage, D; Gijsen, M; Rijnders, B; Spriet, I; Van Daele, R; Van Zwam, K; Wauters, J | 1 |
| Bergmans, DCJJ; Bourgeois, M; Brüggemann, RJM; Buil, JB; Debaveye, Y; Depuydt, P; Feys, S; Hermans, G; Hoiting, O; Jacobs, C; Janssen, NAF; Lagrou, K; Lemiale, V; Lormans, P; Maertens, J; Meersseman, P; Mégarbane, B; Nseir, S; Reynders, M; Rijnders, BJA; Schouten, JA; Spriet, I; Thevissen, K; Thille, AW; Van Daele, R; van de Veerdonk, FL; van der Hoven, B; van Oers, JAH; Vanderbeke, L; Verweij, PE; Wauters, J; Wilmer, A | 1 |
| Irlbeck, M; Jung, J; Kallee, S; Kneidinger, N; Liebchen, U; Michel, S; Paal, M; Scharf, C; Schneider, C; Schroeder, I; Vogeser, M; Zander, J; Zoller, M | 1 |
| Beishuizen, A; Cornet, AD; Masselink, JB; Mian, P; Sportel, ET; Trof, RJ | 1 |
| Bassetti, M; Bouza, E | 1 |
| Chen, SC; Colombo, AL; de Almeida Júnior, JN; Slavin, MA; Sorrell, TC | 1 |
| Butler, J; Lipman, J; Pandey, S; Roberts, JA; Sime, FB; Starr, T; Stuart, J; Wallis, SC | 1 |
| Butler, J; Byrne, CJ; Lipman, J; Pandey, S; Parker, S; Roberts, JA; Sime, FB; Starr, T; Stuart, J; Wallis, SC | 1 |
| Pea, F | 1 |
| Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D | 1 |
| Alanio, A; Benyamina, M; Chaouat, M; Denis, B; Ferry, A; Legrand, M; Maurel, V; Mebazaa, A; Mimoun, M; Padoin, C; Ressaire, Q; Soussi, S | 1 |
| Healy, JR; Kraft, WK; Moore, JN | 1 |
| Kiser, TH; Morris, AA; Mueller, SW; Rower, JE; Washburn, T | 1 |
| Calandra, T; Eggimann, P; Playford, EG | 1 |
| Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L | 1 |
| Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F | 1 |
| Baltopoulos, G; Despotelis, S; Evaggelopoulou, P; Evodia, E; Markantonis, SL; Myrianthefs, P; Panidis, D | 1 |
| Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
| Böhme, A; Heinz, WJ; Silling, G | 1 |
| Garnacho-Montero, J; Jiménez Parrilla, F | 1 |
| Biassoni, C; Borghi, E; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R | 1 |
| Campbell, L; Marriott, D; Nguyen, Q; Ray, J; Rudham, S | 1 |
| Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G | 1 |
| Annaert, P; Brüggemann, RJ; Lagrou, K; Meersseman, P; Spriet, I; Van Wijngaerden, E; Willems, L | 1 |
| Mohammedi, I; Padoin, C; Piens, MA; Robert, D | 1 |
| Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Burhenne, J; von Mach, MA; Weilemann, LS | 1 |
| Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H | 1 |
| Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J | 1 |
| Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG | 1 |
| Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H | 1 |
| Allepuz-Palau, A; Alvarez-Lerma, F; Angeles Leon, M; Garcia, MP; Iruretagoyena, JR; Luque-Gomez, P; Navarro, A; Sanchez-Ruiz, H | 1 |
| Joshi, R; Kohli, V; Sachdev, P; Taneja, V | 1 |
9 review(s) available for triazoles and Critical Illness
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
Topics: Aged; Aged, 80 and over; Azepines; Critical Care; Critical Illness; Delirium; Drug Therapy, Combination; Female; Humans; Indenes; Length of Stay; Male; Middle Aged; Orexin Receptor Antagonists; Randomized Controlled Trials as Topic; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Retrospective Studies; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles | 2020 |
Invasive mould infections in the ICU setting: complexities and solutions.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole | 2017 |
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.
Topics: Antifungal Agents; Biomarkers; Candida; Critical Illness; Decision Support Techniques; Diagnostic Tests, Routine; Echinocandins; Fungi; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Positron-Emission Tomography; Risk Assessment; Triazoles | 2017 |
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
Pharmacologic and clinical evaluation of posaconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles | 2015 |
Antifungals in the ICU.
Topics: Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Fluconazole; Humans; Intensive Care Units; Triazoles | 2008 |
[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Topics: Adult; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Critical Illness; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Microsomes, Liver; Mycoses; Triazoles | 2011 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
8 trial(s) available for triazoles and Critical Illness
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Topics: Adult; Critical Illness; Humans; Influenza, Human; Intensive Care Units; Invasive Pulmonary Aspergillosis; Triazoles | 2021 |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Posaconazole plasma concentrations in critically ill patients.
Topics: Antifungal Agents; Area Under Curve; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Intensive Care Units; Intubation, Gastrointestinal; Male; Middle Aged; Triazoles | 2011 |
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2005 |
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2005 |
28 other study(ies) available for triazoles and Critical Illness
| Article | Year |
|---|---|
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Topics: Aged; Antifungal Agents; COVID-19; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Pulmonary Aspergillosis; Respiratory Distress Syndrome; Triazoles | 2021 |
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study.
Topics: Administration, Intravenous; Antifungal Agents; Critical Illness; Humans; Influenza, Human; Triazoles | 2022 |
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
Topics: COVID-19; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Nitriles; Pyridines; Triazoles | 2022 |
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Nitriles; Triazoles | 2022 |
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation-authors' response.
Topics: Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Nitriles; Triazoles | 2022 |
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.
Topics: Adult; Anti-Bacterial Agents; Critical Illness; Humans; Prospective Studies; Triazoles | 2023 |
Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitriles; Pyridines; Triazoles | 2019 |
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
Topics: Administration, Intravenous; Antifungal Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Triazoles | 2021 |
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations.
Topics: Antifungal Agents; Critical Illness; Humans; Itraconazole; Lung; Retrospective Studies; Transplant Recipients; Triazoles | 2021 |
Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
Topics: Antifungal Agents; COVID-19; Critical Illness; Humans; Pulmonary Aspergillosis; Triazoles | 2022 |
A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration.
Topics: Antifungal Agents; Area Under Curve; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Hemodiafiltration; Humans; Hypoalbuminemia; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Triazoles | 2018 |
Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.
Topics: Administration, Intravenous; Adult; Albumins; Antifungal Agents; Body Mass Index; Critical Illness; Female; Humans; Intensive Care Units; Male; Mass Spectrometry; Middle Aged; Plasma; Prospective Studies; Protein Binding; Severity of Illness Index; Triazoles | 2019 |
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
Muscle diffusion of liposomal amphotericin B and posaconazole in critically ill burn patients receiving continuous hemodialysis.
Topics: Amphotericin B; Antifungal Agents; Burns; Critical Illness; Diffusion; Humans; Liposomes; Mucormycosis; Muscles; Renal Dialysis; Triazoles | 2015 |
Evaluation of Sulfobutylether-β-Cyclodextrin Exposure in a Critically Ill Patient Receiving Intravenous Posaconazole While Undergoing Continuous Venovenous Hemofiltration.
Topics: Administration, Intravenous; Adult; beta-Cyclodextrins; Critical Illness; Cyclodextrins; Female; Hemofiltration; Humans; Triazoles | 2015 |
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2009 |
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2009 |
Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Drug Monitoring; Female; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Middle Aged; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2010 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Dehydrogenase; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Child; Child, Preschool; Critical Illness; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Intensive Care Units; Italy; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Polymerase Chain Reaction; Triazoles; Young Adult | 2011 |
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
Topics: Antifungal Agents; Antiphospholipid Syndrome; Critical Illness; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole | 2006 |
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole | 2008 |
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole | 2008 |
Voriconazole in newborns.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole | 2008 |